Sorafenib and Dacarbazine in Soft Tissue Sarcoma

NCT00837148 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma
Synovial Sarcoma
Leiomyosarcoma
Malignant Peripheral Nerve Sheath Tumor

Interventions

DRUG: Sorafenib and Dacarbazine

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]